Finance

Lists
6534:TPE
CH Biotech R&D Co Ltd
94,50 NT$
+0,53%
(+0,50) 1D
8 қаз., 13:30:13 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6534...
Open
94,50 NT$
High
95,40 NT$
Low
94,50 NT$
Mkt. cap
9,71 млрд
Avg. vol.
42,15 мың
Volume
180,07 м.
Dividend
5,62%
Quarterly dividend
1,33 NT$
Ex-dividend date
2026 ж. 01 қыр.
P/E ratio
16,11
52-wk high
116,00 NT$
52-wk low
77,60 NT$
EPS
5,87 NT$
No. of employees
22
Open
94,50 NT$
High
95,40 NT$
Low
94,50 NT$
Mkt. cap
9,71 млрд
Avg. vol.
42,15 мың
Volume
180,07 м.
Dividend
5,62%
Quarterly dividend
1,33 NT$
Ex-dividend date
2026 ж. 01 қыр.
P/E ratio
16,11
52-wk high
116,00 NT$
52-wk low
77,60 NT$
EPS
5,87 NT$
No. of employees
22
News stories
From web sources and news partners
About CH Biotech R&D Co Ltd
CEO-
Employees22
Founded2013
Headquarters-
Sector-
Websitechbio.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
216,68 млн
328,38 млн
869,50 млн
459,43 млн
Cost of goods sold
44,23 млн
63,38 млн
120,11 млн
69,52 млн
Cost of revenue
44,23 млн
63,38 млн
120,11 млн
69,52 млн
Research and development expenses
121,72 млн
98,86 млн
99,04 млн
101,73 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
99,03 млн
124,14 млн
132,18 млн
117,46 млн
Operating expense
221,16 млн
223,35 млн
231,23 млн
219,18 млн
Total operating expenses
265,39 млн
286,73 млн
351,33 млн
288,70 млн
Operating income
-48,71 млн
41,65 млн
518,17 млн
170,72 млн
Other non operating income
1,70 млн
1,73 млн
1,08 млн
1,72 млн
EBT including unusual items
-21,67 млн
59,12 млн
532,25 млн
166,60 млн
EBT excluding unusual items
-21,19 млн
59,24 млн
532,25 млн
166,60 млн
Income tax expense
-4,69 млн
15,34 млн
105,55 млн
15,47 млн
Effective tax rate
21,64%
25,94%
19,83%
9,28%
Other operating expenses
-
-
-
-
Net income
-16,94 млн
43,80 млн
426,70 млн
151,13 млн
Net profit margin
-7,82%
13,34%
49,07%
32,89%
Earnings per share
-
-
-
-
Interest and investment income
3,86 млн
2,72 млн
2,58 млн
3,00 млн
Interest expense
-4,90 млн
-3,58 млн
-3,28 млн
-4,39 млн
Net interest expenses
-1,04 млн
-853,00 м.
-703,00 м.
-1,39 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,48 млн
88,81 млн
566,17 млн
218,60 млн
Gain or loss from assets sale
478,00 м.
122,00 м.
-
-
AI content may include mistakes. Learn more
Google қолданбалары